Your browser doesn't support javascript.
loading
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer.
Stenehjem, David D; Yoo, Minkyoung; Unni, Sudhir K; Singhal, Mukul; Bauer, Hillevi; Saverno, Kim; Quah, Cheng; Masaquel, Anthony; Brixner, Diana I.
Afiliação
  • Stenehjem DD; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA ; Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Yoo M; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Unni SK; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Singhal M; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Bauer H; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Saverno K; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Quah C; Genentech, Inc., South San Francisco, CA, USA.
  • Masaquel A; Genentech, Inc., South San Francisco, CA, USA.
  • Brixner DI; Pharmacotherapy Outcomes Research Center (PORC), College of Pharmacy, University of Utah, Salt Lake City, UT, USA ; Program in Personalized Health Care, University of Utah, Salt Lake City, UT, USA.
Article em En | MEDLINE | ID: mdl-25378949

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Breast Cancer (Dove Med Press) Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Breast Cancer (Dove Med Press) Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos